These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
213 related articles for article (PubMed ID: 35011736)
21. Transmembrane protein 170B is a novel breast tumorigenesis suppressor gene that inhibits the Wnt/β-catenin pathway. Li M; Han Y; Zhou H; Li X; Lin C; Zhang E; Chi X; Hu J; Xu H Cell Death Dis; 2018 Jan; 9(2):91. PubMed ID: 29367600 [TBL] [Abstract][Full Text] [Related]
22. H19 non coding RNA-derived miR-675 enhances tumorigenesis and metastasis of breast cancer cells by downregulating c-Cbl and Cbl-b. Vennin C; Spruyt N; Dahmani F; Julien S; Bertucci F; Finetti P; Chassat T; Bourette RP; Le Bourhis X; Adriaenssens E Oncotarget; 2015 Oct; 6(30):29209-23. PubMed ID: 26353930 [TBL] [Abstract][Full Text] [Related]
23. MiR-93 suppresses tumorigenesis and enhances chemosensitivity of breast cancer via dual targeting E2F1 and CCND1. Bao C; Chen J; Chen D; Lu Y; Lou W; Ding B; Xu L; Fan W Cell Death Dis; 2020 Aug; 11(8):618. PubMed ID: 32796817 [TBL] [Abstract][Full Text] [Related]
24. Inhibition of Ovarian Epithelial Carcinoma Tumorigenesis and Progression by microRNA 106b Mediated through the RhoC Pathway. Chen S; Chen X; Xiu YL; Sun KX; Zhao Y PLoS One; 2015; 10(5):e0125714. PubMed ID: 25933027 [TBL] [Abstract][Full Text] [Related]
25. The Dual Regulatory Role of MiR-181a in Breast Cancer. Yang C; Tabatabaei SN; Ruan X; Hardy P Cell Physiol Biochem; 2017; 44(3):843-856. PubMed ID: 29176320 [TBL] [Abstract][Full Text] [Related]
26. MiR-190b, the highest up-regulated miRNA in ERα-positive compared to ERα-negative breast tumors, a new biomarker in breast cancers? Cizeron-Clairac G; Lallemand F; Vacher S; Lidereau R; Bieche I; Callens C BMC Cancer; 2015 Jul; 15():499. PubMed ID: 26141719 [TBL] [Abstract][Full Text] [Related]
27. Breast cancer and microRNAs: therapeutic impact. Iorio MV; Casalini P; Piovan C; Braccioli L; Tagliabue E Breast; 2011 Oct; 20 Suppl 3():S63-70. PubMed ID: 22015296 [TBL] [Abstract][Full Text] [Related]
28. MicroRNA-567 dysregulation contributes to carcinogenesis of breast cancer, targeting tumor cell proliferation, and migration. Bertoli G; Cava C; Diceglie C; Martelli C; Rizzo G; Piccotti F; Ottobrini L; Castiglioni I Breast Cancer Res Treat; 2017 Feb; 161(3):605-616. PubMed ID: 28000015 [TBL] [Abstract][Full Text] [Related]
29. The role of miR-100 in regulating apoptosis of breast cancer cells. Gong Y; He T; Yang L; Yang G; Chen Y; Zhang X Sci Rep; 2015 Jul; 5():11650. PubMed ID: 26130569 [TBL] [Abstract][Full Text] [Related]
30. Increased Cellular Levels of MicroRNA-9 and MicroRNA-221 Correlate with Cancer Stemness and Predict Poor Outcome in Human Breast Cancer. Cheng CW; Yu JC; Hsieh YH; Liao WL; Shieh JC; Yao CC; Lee HJ; Chen PM; Wu PE; Shen CY Cell Physiol Biochem; 2018; 48(5):2205-2218. PubMed ID: 30110679 [TBL] [Abstract][Full Text] [Related]
31. Essential role of miR-200c in regulating self-renewal of breast cancer stem cells and their counterparts of mammary epithelium. Feng ZM; Qiu J; Chen XW; Liao RX; Liao XY; Zhang LP; Chen X; Li Y; Chen ZT; Sun JG BMC Cancer; 2015 Sep; 15():645. PubMed ID: 26400441 [TBL] [Abstract][Full Text] [Related]
32. Role of deregulated microRNAs in breast cancer progression using FFPE tissue. Chen L; Li Y; Fu Y; Peng J; Mo MH; Stamatakos M; Teal CB; Brem RF; Stojadinovic A; Grinkemeyer M; McCaffrey TA; Man YG; Fu SW PLoS One; 2013; 8(1):e54213. PubMed ID: 23372687 [TBL] [Abstract][Full Text] [Related]
33. LRG1 mRNA expression in breast cancer associates with PIK3CA genotype and with aromatase inhibitor therapy outcome. Ramirez-Ardila DE; Ruigrok-Ritstier K; Helmijr JC; Look MP; van Laere S; Dirix L; Berns EM; Jansen MP Mol Oncol; 2016 Oct; 10(8):1363-73. PubMed ID: 27491861 [TBL] [Abstract][Full Text] [Related]
34. Dysregulated miR-183 inhibits migration in breast cancer cells. Lowery AJ; Miller N; Dwyer RM; Kerin MJ BMC Cancer; 2010 Sep; 10():502. PubMed ID: 20858276 [TBL] [Abstract][Full Text] [Related]
35. MiR-105-3p acts as an oncogene to promote the proliferation and metastasis of breast cancer cells by targeting GOLIM4. Lin B; Liu C; Shi E; Jin Q; Zhao W; Wang J; Ji R BMC Cancer; 2021 Mar; 21(1):275. PubMed ID: 33722196 [TBL] [Abstract][Full Text] [Related]
36. MicroRNA-203 reinforces stemness properties in melanoma and augments tumorigenesis in vivo. Sahranavardfard P; Firouzi J; Azimi M; Khosravani P; Heydari R; Emami Razavi A; Dorraj M; Keighobadi F; Ebrahimi M J Cell Physiol; 2019 Nov; 234(11):20193-20205. PubMed ID: 31016725 [TBL] [Abstract][Full Text] [Related]
37. circSLC8A1 sponges miR-671 to regulate breast cancer tumorigenesis via PTEN/PI3k/Akt pathway. Zhu Q; Zhang X; Zai HY; Jiang W; Zhang KJ; He YQ; Hu Y Genomics; 2021 Jan; 113(1 Pt 1):398-410. PubMed ID: 33301895 [TBL] [Abstract][Full Text] [Related]
38. Han family with essential tremor caused by the P421L variant of the TENM4 gene in China. Chi W; Wu M; Wang HL; Wu QY; Zhang YP; Hu YN; Zhu YB; Lin XF; Chen T; Luo JW; Ruan XL; Li YF Neurol Sci; 2023 Jun; 44(6):2003-2015. PubMed ID: 36689009 [TBL] [Abstract][Full Text] [Related]
39. A novel miR-1291-ERRα-CPT1C axis modulates tumor cell proliferation, metabolism and tumorigenesis. Chen Y; Zhou Y; Han F; Zhao Y; Tu M; Wang Y; Huang C; Fan S; Chen P; Yao X; Guan L; Yu AM; Gonzalez FJ; Huang M; Bi H Theranostics; 2020; 10(16):7193-7210. PubMed ID: 32641987 [No Abstract] [Full Text] [Related]
40. MicroRNA-494 inhibits breast cancer progression by directly targeting PAK1. Zhan MN; Yu XT; Tang J; Zhou CX; Wang CL; Yin QQ; Gong XF; He M; He JR; Chen GQ; Zhao Q Cell Death Dis; 2017 Jan; 8(1):e2529. PubMed ID: 28055013 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]